UBQLN2 and synucleinopathy: Previous studies showed ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies [46] and provided evidence that UBQLN2 dysregulation may contribute to α-synuclein-mediated toxicity [47].